The Asian Transcatheter Aortic Valve Replacement Registry
- Conditions
- Aortic Valve StenosisAortic Diseases
- Registration Number
- NCT02308150
- Lead Sponsor
- Seung-Jung Park
- Brief Summary
The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve replacement (TAVR) in the Asian Pacific population
- Detailed Description
This registry changes to TP-TAVR registry(NCT03826264). Some subjects moved to TP-TAVR registry and continue to 10-year follow-up.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1505
- Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death 5 years
- Secondary Outcome Measures
Name Time Method Stroke 5 years Repeat hospitalization 5 years Bleeding events 5 years Death from cardiac cause 5 years Vascular complication 5 years Device success 5 years Acute kidney injury 5 years Myocardial infarction 5 years
Trial Locations
- Locations (12)
National University Heart Centre
🇸🇬Singapore, Singapore
Queen Elizabeth Hospital
🇨🇳Hong Kong, China
Teikyo University School of medicine
🇯🇵Tokyo, Japan
Saiseikai Yokohama-city Eastern Hospital
🇯🇵Yokohama, Japan
Shonan Kamakura General Hospital
🇯🇵Kamakura, Japan
Kokura Memorial Hospital
🇯🇵Kitakyushu, Japan
Keio University
🇯🇵Minato, Japan
Sejong Hospital
🇰🇷Bucheon, Korea, Republic of
Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of
Chungnam National University Hospital
🇰🇷Daejeon, Korea, Republic of
National Taiwan University
🇨🇳Taipei, Taiwan
Asan Medical Center
🇰🇷Seoul, Songpa-gu, Korea, Republic of